Thus, treatment with TriMix-DC further expanded the pre-existing MAGE-C2 response and additionally induced de novo responses restricted to other MAA that are included in the DC therapy. documented a partial tumor response according to RECIST criteria with a marked reduction in18F-FDG-uptake by lung, lymph node and bone metastases. The patient remains free from progression after […]